Myocardial Ischemia After Coronary Sinus Reduction Stent Implantation

Launched by OSLO UNIVERSITY HOSPITAL · Sep 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment option for patients suffering from severe chest pain known as refractory angina, which doesn’t improve with standard medications or procedures. The researchers are looking at a device called a coronary sinus reduction stent, which is implanted in a specific part of the heart to help improve blood flow and reduce the pain and discomfort associated with angina. The main goal of the study is to see if this stent can actually improve blood flow to the heart muscle and, in turn, help patients feel better and have a better quality of life.

To participate in the trial, patients need to have coronary artery disease and experience ongoing chest pain that hasn’t been relieved by other treatments. They must also be suitable for the stent procedure and agree to follow the study guidelines. During the trial, participants will undergo tests before receiving the stent and again after six months to see how their heart function and symptoms change. Importantly, the study will ensure that the results are accurate and unbiased by using detailed imaging techniques that don’t reveal whether the stent is present during evaluations. This research could provide valuable information on new ways to help patients with refractory angina feel better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Coronary artery disease and refractory angina
• • Clinical indication for coronary sinus reduction stent implantation
• • Written informed consent
• • Anticipated compliance with protocol
• Exclusion Criteria:
• • Ineligibility for coronary sinus reduction stent implantation
• • Lack of informed consent
• • Not expected to comply with protocol